"While we know that the single dose can protect against disease" seems like a strong statement - these were post hoc analyses, right? Your piece doesn't help any reader understand why post hoc analyses are problematic.
-
-
(So maybe another piece: you may have heard we're trialing single-dose and/or some governor is suggesting a single-dose! Unless you're in that trial, please go get your second dose and/or states please make sure to put resources in follow-up, starting with higher risk). /n
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Broadly, yes, misinfo can't be walled off. Hence, all about how to either optimally address when such studies like the mask study get attention by influencers and are used in bad/unhelpful ways or in rare cases get ahead of the unwarranted hype.
-
So this is too interesting to discuss in tweets, but my sense is that the best way to get ahead of it is to run with it, before they do, but in an accurate and comprehensive way. Acknowledge shortcomings, etc. Somewhat based on research on "data voids" +
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.